GB0130339D0 - Isochroman compounds - Google Patents
Isochroman compoundsInfo
- Publication number
- GB0130339D0 GB0130339D0 GBGB0130339.5A GB0130339A GB0130339D0 GB 0130339 D0 GB0130339 D0 GB 0130339D0 GB 0130339 A GB0130339 A GB 0130339A GB 0130339 D0 GB0130339 D0 GB 0130339D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- isochroman compounds
- isochroman
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- HEBMCVBCEDMUOF-UHFFFAOYSA-N isochromane Chemical class C1=CC=C2COCCC2=C1 HEBMCVBCEDMUOF-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/76—Benzo[c]pyrans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130339.5A GB0130339D0 (en) | 2001-12-19 | 2001-12-19 | Isochroman compounds |
| TW091133608A TW200301116A (en) | 2001-12-19 | 2002-11-18 | Isochroman compounds |
| PCT/US2002/036148 WO2003053948A1 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of cns disorders |
| EP02793911A EP1458703B1 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of cns disorders |
| AT02793911T ATE355283T1 (de) | 2001-12-19 | 2002-12-06 | Isochroman verbindungen für die behandlung von cns-krankheiten |
| BR0214859-5A BR0214859A (pt) | 2001-12-19 | 2002-12-06 | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de um mamìfero, incluindo um humano, sofrendo de ou suscetìvel a um distúrbio do sistema nervoso central |
| PT02793911T PT1458703E (pt) | 2001-12-19 | 2002-12-06 | Compostos isocromano para o tratamento de perturbações do snc |
| JP2003554664A JP2005516952A (ja) | 2001-12-19 | 2002-12-06 | 中枢神経系疾患の治療のためのイソクロマン化合物 |
| ES02793911T ES2280606T3 (es) | 2001-12-19 | 2002-12-06 | Compuestos isocromano para el tratamiento de trastornos del snc. |
| US10/496,535 US7335660B2 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of CNS disorders |
| SI200230528T SI1458703T1 (sl) | 2001-12-19 | 2002-12-06 | Izokromanske spojine za zdravljenje motenj centralnega živčnega sistema |
| CA002469278A CA2469278A1 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of cns disorders |
| MXPA04006085A MXPA04006085A (es) | 2001-12-19 | 2002-12-06 | Compuestos de isocromano para el tratamiento de trastornos del sistema nervioso central. |
| DE60218529T DE60218529T2 (de) | 2001-12-19 | 2002-12-06 | Isochroman verbindungen für die behandlung von cns-krankheiten |
| CNB028281209A CN1312148C (zh) | 2001-12-19 | 2002-12-06 | 用于治疗中枢神经系统疾病的异色满化合物 |
| DK02793911T DK1458703T3 (da) | 2001-12-19 | 2002-12-06 | Isochromanforbindelser til behandling af CNS-lidelser |
| AU2002359378A AU2002359378B8 (en) | 2001-12-19 | 2002-12-06 | Isochroman compounds for treatment of CNS disorders |
| PE2002001229A PE20030728A1 (es) | 2001-12-19 | 2002-12-13 | Compuestos de isocromano |
| ARP020104961A AR038662A1 (es) | 2001-12-19 | 2002-12-18 | Compuestos de isocromano |
| SV2002001441A SV2004001441A (es) | 2001-12-19 | 2002-12-19 | Compuestos de isocromano ref. x-14205 |
| CY20071100573T CY1106552T1 (el) | 2001-12-19 | 2007-04-26 | Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0130339.5A GB0130339D0 (en) | 2001-12-19 | 2001-12-19 | Isochroman compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0130339D0 true GB0130339D0 (en) | 2002-02-06 |
Family
ID=9927920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0130339.5A Ceased GB0130339D0 (en) | 2001-12-19 | 2001-12-19 | Isochroman compounds |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1458703B1 (https=) |
| JP (1) | JP2005516952A (https=) |
| CN (1) | CN1312148C (https=) |
| AR (1) | AR038662A1 (https=) |
| AT (1) | ATE355283T1 (https=) |
| AU (1) | AU2002359378B8 (https=) |
| BR (1) | BR0214859A (https=) |
| CA (1) | CA2469278A1 (https=) |
| CY (1) | CY1106552T1 (https=) |
| DE (1) | DE60218529T2 (https=) |
| DK (1) | DK1458703T3 (https=) |
| ES (1) | ES2280606T3 (https=) |
| GB (1) | GB0130339D0 (https=) |
| MX (1) | MXPA04006085A (https=) |
| PE (1) | PE20030728A1 (https=) |
| PT (1) | PT1458703E (https=) |
| SI (1) | SI1458703T1 (https=) |
| SV (1) | SV2004001441A (https=) |
| TW (1) | TW200301116A (https=) |
| WO (1) | WO2003053948A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| NL2000351C2 (nl) | 2005-12-22 | 2007-09-11 | Pfizer Prod Inc | Estrogeen-modulatoren. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4247553A (en) * | 1977-10-31 | 1981-01-27 | The Upjohn Company | Methods of treating psychosis |
| CA2176722A1 (en) * | 1993-12-28 | 1995-07-06 | Ruth E. Ten Brink | Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
| PL324319A1 (en) * | 1995-06-30 | 1998-05-25 | Upjohn Co | 1,6-disubstituted isochromates for fighting against sick headaches |
| GB2370270A (en) * | 2000-12-20 | 2002-06-26 | Lilly Co Eli | Pharmaceutical compounds |
-
2001
- 2001-12-19 GB GBGB0130339.5A patent/GB0130339D0/en not_active Ceased
-
2002
- 2002-11-18 TW TW091133608A patent/TW200301116A/zh unknown
- 2002-12-06 SI SI200230528T patent/SI1458703T1/sl unknown
- 2002-12-06 CA CA002469278A patent/CA2469278A1/en not_active Abandoned
- 2002-12-06 ES ES02793911T patent/ES2280606T3/es not_active Expired - Lifetime
- 2002-12-06 AT AT02793911T patent/ATE355283T1/de not_active IP Right Cessation
- 2002-12-06 DK DK02793911T patent/DK1458703T3/da active
- 2002-12-06 DE DE60218529T patent/DE60218529T2/de not_active Expired - Lifetime
- 2002-12-06 AU AU2002359378A patent/AU2002359378B8/en not_active Ceased
- 2002-12-06 WO PCT/US2002/036148 patent/WO2003053948A1/en not_active Ceased
- 2002-12-06 JP JP2003554664A patent/JP2005516952A/ja not_active Ceased
- 2002-12-06 MX MXPA04006085A patent/MXPA04006085A/es active IP Right Grant
- 2002-12-06 BR BR0214859-5A patent/BR0214859A/pt not_active IP Right Cessation
- 2002-12-06 PT PT02793911T patent/PT1458703E/pt unknown
- 2002-12-06 CN CNB028281209A patent/CN1312148C/zh not_active Expired - Fee Related
- 2002-12-06 EP EP02793911A patent/EP1458703B1/en not_active Expired - Lifetime
- 2002-12-13 PE PE2002001229A patent/PE20030728A1/es not_active Application Discontinuation
- 2002-12-18 AR ARP020104961A patent/AR038662A1/es unknown
- 2002-12-19 SV SV2002001441A patent/SV2004001441A/es not_active Application Discontinuation
-
2007
- 2007-04-26 CY CY20071100573T patent/CY1106552T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1458703E (pt) | 2007-05-31 |
| DK1458703T3 (da) | 2007-06-11 |
| CN1312148C (zh) | 2007-04-25 |
| CY1106552T1 (el) | 2012-01-25 |
| EP1458703A1 (en) | 2004-09-22 |
| BR0214859A (pt) | 2004-11-03 |
| AR038662A1 (es) | 2005-01-26 |
| DE60218529D1 (de) | 2007-04-12 |
| TW200301116A (en) | 2003-07-01 |
| ATE355283T1 (de) | 2006-03-15 |
| CN1620447A (zh) | 2005-05-25 |
| PE20030728A1 (es) | 2003-08-29 |
| WO2003053948A1 (en) | 2003-07-03 |
| JP2005516952A (ja) | 2005-06-09 |
| ES2280606T3 (es) | 2007-09-16 |
| AU2002359378B2 (en) | 2008-08-21 |
| SV2004001441A (es) | 2004-05-07 |
| EP1458703B1 (en) | 2007-02-28 |
| AU2002359378A1 (en) | 2003-07-09 |
| CA2469278A1 (en) | 2003-07-03 |
| DE60218529T2 (de) | 2007-11-22 |
| SI1458703T1 (sl) | 2007-08-31 |
| MXPA04006085A (es) | 2004-09-27 |
| AU2002359378B8 (en) | 2008-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002349297A8 (en) | Statin-like compounds | |
| GB0126433D0 (en) | Compounds | |
| GB0124463D0 (en) | Compounds | |
| GB0102668D0 (en) | Compounds | |
| GB0112324D0 (en) | Compounds | |
| GB0102665D0 (en) | Compounds | |
| GB0121488D0 (en) | Compounds | |
| GB0102673D0 (en) | Compounds | |
| GB0119474D0 (en) | Compounds | |
| GB0130339D0 (en) | Isochroman compounds | |
| GB0119472D0 (en) | Compounds | |
| GB0118364D0 (en) | Compounds | |
| GB0115178D0 (en) | Compounds | |
| GB0108097D0 (en) | Compounds | |
| GB0119473D0 (en) | Compounds | |
| GB0120344D0 (en) | Compounds | |
| GB0104396D0 (en) | Compounds | |
| GB0102661D0 (en) | Compounds | |
| GB0106673D0 (en) | Compounds | |
| GB0104401D0 (en) | Compounds | |
| GB0111183D0 (en) | Compounds | |
| GB0104399D0 (en) | Compounds | |
| GB0111189D0 (en) | Compounds | |
| GB0104398D0 (en) | Compounds | |
| GB0114291D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |